Linear competitive inhibition of human tissue kallikrein by 4-aminobenzamidine and benzamidine and linear mixed inhibition by 4-nitroaniline and aniline

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 1, 2001, Pages 35-44

  Sousa, M O ^a   Miranda, T L S ^a   Costa, E B ^a   Bittar, E R ^a   Santoro, M M ^a   Figueiredo, A F S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

4 aminobenzamidine; 4 nitroaniline; Aniline; Benzamidine; Enzyme inhibition; Kinetics of human tissue kallikrein inhibition; Tissue kallikrein

Indexed keywords

4 AMINOBENZAMIDINE; 4 NITROANILINE; 4-AMINOBENZAMIDINE; 4-NITROANILINE; AMIDASE; AMYLASE; ANILINE DERIVATIVE; BENZAMIDINE DERIVATIVE; CHROMOGENIC SUBSTRATE; OLIGOPEPTIDE; TISSUE KALLIKREIN; TRYPSIN INHIBITOR; VAL LEU ARG P NITROANILIDE; VAL-LEU-ARG-P-NITROANILIDE; VEGETABLE PROTEIN;

ARTICLE; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; HYDROLYSIS; METABOLISM; STATISTICAL MODEL;

ALPHA-AMYLASE; AMIDOHYDROLASES; ANILINE COMPOUNDS; BENZAMIDINES; BINDING SITES; CHROMOGENIC COMPOUNDS; HUMANS; HYDROLYSIS; LINEAR MODELS; OLIGOPEPTIDES; PLANT PROTEINS; TISSUE KALLIKREINS; TRYPSIN INHIBITORS;

EID: 0035227870     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000100004     Document Type: Article

References (26)

1. Bhoola KD, Figueroa CD & Worthy K (1992). Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacological Reviews, 44: 1-80.
2. MacDonald RJ, Margolius HS & Erdös EG (1988). Molecular biology of tissue kallikrein. Biochemical Journal, 253: 313-321
3. Del Nery E, Chagas JR, Juliano MA, Prado ES & Juliano L (1995). Evaluation of the extent of the binding site in human tissue kallikrem by synthetic substrates with sequences of human kininogen fragments Biochemical Journal, 312: 233-238.
4. Berg T, Bradshaw RA, Carretero OA, Chao J, Chao L, Clements JA, Fahnestock M, Fritz H, Gauthier F, MacDonald RJ, Margolius HS, Morris BJ, Richards RI & Scicli AG (1992) A common nomenclature for members of the tissue (glandular) kallikrein gene families. Agents and Actions, 38 (Suppl): 19-25.
5. Schachter M (1980). Kallikreins (kininogenases) - A group of serine proteases with bioregulatory actions. Pharmacological Reviews, 31: 1-17.
6. Geiger R & Fritz H (1981). Human urinary kallikrein. Methods in Enzymology, 80: 466-492.
7. Antonini E, Ascenzi P, Menegatti E, Bortolotti F & Guarneri M (1982). Catalytic properties of human urinary kallikrein. Biochemistry, 21: 2477-2482.
8. Chagas JR, Portaro FCV, Hirata IY, Almeida PC, Juliano MA, Juliano L & Prado ES (1995). Determinants of the urusual cleavage specificity of lysyl-bradyk -nin-releasing kallikreins. Biochemical Journal, 306: 63-69.
9. Hial V, Diniz CR & Mares-Guia M (1974). Purification and properties of a human urinary kallikrein (kininogenase). Biochemistry, 13: 4311-4318.
10. Geiger R, Mann K & Bettels T (1977). Isolation of human urinary kallikrein by affinity chromatography. Journal of Clinical Chemistry and Clinical Biochemistry, 15: 479-483.
11. Kettner C, Mirabelli C, Pierce JV & Shaw E (1980). Active site mapping of human and rat urinary kallikreins by peptidyl chloromethyl ketones. Archives of Biochemistry and Biophysics, 202: 420-430.
12. Miranda TLS, Ramos CHI, Freire RTS, Souza EP, Rogana E, Santoro MM & Figueiredo AFS (1995). Kinetic mechanism of the inhibition of human urinary kallikrein by basic pancreatic trypsin inhibitor. Brazilian Journal of Medical and Biological Research, 28: 505-512.
13. Rogana E, Nelson DL & Mares-Guia M (1975). Characterization of the ultraviolet absorption spectra of para-substituted derivatives of benzamidme. Journal of the American Chemical Society, 97: 6844-6848.
14. Plowman KM (1972), Inhibitor studies. In: Hume DN, Stork G, King EL, Herschbach DR & People JA (Editors), Enzyme Kinetics. McGraw-Hill Book Company, New York, 56-75.
15. Cornish-Bowden A (1981). Inhibitors and activators. In: Cornish-Bowden A (Editor), Fundamentals of Enzyme Kinetics, Butterworth & Co., Ltd., London, 73-98.
16. Cram DJ & Hammond GS (1964). Physical properties In: Cram DJ & Hammond GS (Editors), Organic Chemistry. McGraw-Hill Book Company, New York, 183-225.
17. Mares-Guia M & Shaw E (1965). Studies on the active center of trypsin. Journal of Biological Chemistry, 210: 1579-1585
18. Katz BA, Liu B, Barnes M & Springman EB (1998). Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution. Protein Science, 7: 875-885.
19. Ascenzi P, Menegatti E, Guarneri M, Bortolotti F & Antonini E (1982). Catalytic properties of senne proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine β-trypsin, bovine thrombin, and bovine α-chymotrypsin. Biochemistry, 21: 2483-2490.
20. Schechter I & Berger A (1967). On the size of the active site in proteases. I. Papain. Biochemical and Biophysical Research Communications, 27: 157-162.
21. Chen Z & Bode W (1983). Refined 2.5 Å X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine oancreatic trypsin inhibitor. Journal of Molecular Biology, 164: 283-310.
22. Weber G (1992). Transfer of proteins to apolar media and the dynamic interactions of proteins and memoranes. In: Weber G (Editor), Protein Interactions. Routledge, Chapman & Hall, Inc., New York, 161-176.
23. Riordan JF, McElvany KD & Borders Jr CL (1976). Arginyl residues: anion recognition sites in enzymes. Science, 195: 884-886.
24. Paddlan EA, Davis D, Rudikoft S & Potter EM (1976). Structural basis for the specificity of phosphorylcholine-binding immunoglobulins. Immunochemistry, 13: 945-949.
25. Segel IH (1975). Rapid equilibrium partial and mixed-type inhibition. In: Segel IH (Editor), Enzyme Kinetics. John Wiley & Sons, New York, 161-226.
26. Mares-Guia M, Nelson DL & Rogana E (1977). Electronic effects in the interaction of para-substituted benzamidines with trypsin: the involvement of the Π-electronic density at the central atom of the substituent in binding. Journal of the American Chemical Society, 99: 2331-2336.